U.S. Markets open in 15 hrs, 36 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,288.54 | 73.03 | 0.65% |
| NASDAQ | 2,245.38 | -6.08 | -0.27% |
| S&P 500 | 1,262.90 | 1.38 | 0.11% |
| Day Low 10:04 AM EDT | 33.09 | |
|---|---|---|
| Day High 09:30 AM EDT | 34.41 |
|
| Range | 1.32 | |
| Volume | 1.28 M | |
| 30-Day Avg. Vol. | 2.56 M |
|
| Difference | -49.90% | |
| Market Cap. | 4.77 B | |
| Change | -8.43 M | |
| Shares Out. | 140.56 M | |
| Percent Traded | 0.91% | |
| Revenue | 199.01 M | |
| Earnings | -391.27 M | |
| EPS (TTM) | -3.10 |
| 52-Wk Low 3/11/08 | 13.84 | |
|---|---|---|
| 52-Wk High 9/6/07 | 41.42 |
|
| Range | 27.58 | |
| Prev. Close 7/2/08 | 34.03 | |
| Today's Open | 34.31 | |
| Change | 0.82% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 1.4256 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | — |
Vertex Pharmaceuticals represents the convergence of drug discovery technologies. The biotechnology company uses an integrated, multidisciplinary approach -- employing biophysics, computer-based modeling, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.656 12/31/07 | -0.66 12/31/07 |
-0.004
Missed
|
| Last Quarter | -0.666 3/31/08 | -0.72 3/31/08 |
-0.054
Missed
|
| Quarterly - 03/31/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 41.68 M | 199.01 M |
| Gross Profit | 30.60 M | 157.65 M |
| Operating Income | -98.11 M | -412.67 M |
| Net Income | -96.15 M | -391.28 M |
